Discover
XBIO
Xenetic Biosciences, Inc.
2.94
2 x 2.04
2 x 3.71
bid
ask
+
0.03
1.03%
2 @ 04:00 PM
2.89 -0.05 (1.70%)
| Ytd | 35.48% | |
| 1y | -21.60% |
2.87
day range
2.94
1.90
52 week range
13.93
| Open | 2.88 | Prev Close | 2.91 | Low | 2.87 | High | 2.94 | Mkt Cap | 6.74M |
| Vol | 8.08K | Avg Vol | 16.50K | EPS | -1.19 | P/E | N/A | Forward P/E | -6.20 |
| Beta | 2.26 | Short Ratio | 0.77 | Inst. Own | 2.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 3.06 | 200-d Avg | 2.94 | 1yr Est | 4.00 |
XBIO News
benzinga.com
Xenetic Biosciences Announces That Its Collaboration Partner PeriNess Received Israeli Ministry Of H
This approval follows positive preclinical results that demonstrated significant improvement of CAR
benzinga.com
Xenetic Biosciences Reports ASCO 2026 Data Showing DNase I Boosts CAR-T Expansion And Anti-Tumor Act
New preclinical and translational findings position DNase I as a potentially transformative adjunct